Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K T Preissner

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Microvascular Research|September 1, 1987
Microvascular endothelial cells from human omental tissue: modified method for long-term cultivation and new aspects of characterizationE Anders, J U Alles, U Delvos, et al.
Placenta|March 27, 2007
HCG in the regulation of placental angiogenesis. Results of an in vitro studyF Herr, N Baal, K Reisinger, et al.
Biochimica Et Biophysica Acta|May 12, 1988
Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerizationW Ruf, A Bender, D A Lane, et al.
The Journal of Biological Chemistry|August 5, 1990
Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory propertiesH J Ehrlich, R K Gebbink, J Keijer, et al.
Thrombosis and Haemostasis|May 24, 2000
Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix FS L Schousboe, R Egelund, T Kirkegaard, et al.
European Journal of Biochemistry|June 15, 1991
Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin IIIT Koyama, J F Parkinson, P Sié, et al.
Blood|August 15, 1994
Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membraneA Zanetti, G Conforti, S Hess, et al.
Thrombosis and Haemostasis|March 1, 1997
The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activatorM van Meijer, A Stoop, A Smilde, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1996
Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retinaH P Hammes, A Weiss, S Hess, et al.
British Journal of Haematology|August 1, 1991
Relationship between post-translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulinT Koyama, J F Parkinson, N Aoki, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Microvascular Research|September 1, 1987
Microvascular endothelial cells from human omental tissue: modified method for long-term cultivation and new aspects of characterizationE Anders, J U Alles, U Delvos, et al.
Placenta|March 27, 2007
HCG in the regulation of placental angiogenesis. Results of an in vitro studyF Herr, N Baal, K Reisinger, et al.
Biochimica Et Biophysica Acta|May 12, 1988
Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerizationW Ruf, A Bender, D A Lane, et al.
The Journal of Biological Chemistry|August 5, 1990
Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory propertiesH J Ehrlich, R K Gebbink, J Keijer, et al.
Thrombosis and Haemostasis|May 24, 2000
Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix FS L Schousboe, R Egelund, T Kirkegaard, et al.
European Journal of Biochemistry|June 15, 1991
Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin IIIT Koyama, J F Parkinson, P Sié, et al.
Blood|August 15, 1994
Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membraneA Zanetti, G Conforti, S Hess, et al.
Thrombosis and Haemostasis|March 1, 1997
The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activatorM van Meijer, A Stoop, A Smilde, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1996
Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retinaH P Hammes, A Weiss, S Hess, et al.
British Journal of Haematology|August 1, 1991
Relationship between post-translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulinT Koyama, J F Parkinson, N Aoki, et al.
Pageof 15